Natural killer cells in cancer immunotherapy

Citations Over TimeTop 10% of 2024 papers

Abstract

Natural killer (NK) cells, as innate lymphocytes, possess cytotoxic capabilities and engage target cells through a repertoire of activating and inhibitory receptors. Particularly, natural killer group 2, member D (NKG2D) receptor on NK cells recognizes stress-induced ligands-the MHC class I chain-related molecules A and B (MICA/B) presented on tumor cells and is key to trigger the cytolytic response of NK cells. However, tumors have developed sophisticated strategies to evade NK cell surveillance, which lead to failure of tumor immunotherapy. In this paper, we summarized these immune escaping strategies, including the downregulation of ligands for activating receptors, upregulation of ligands for inhibitory receptors, secretion of immunosuppressive compounds, and the development of apoptosis resistance. Then, we focus on recent advancements in NK cell immune therapies, which include engaging activating NK cell receptors, upregulating NKG2D ligand MICA/B expression, blocking inhibitory NK cell receptors, adoptive NK cell therapy, chimeric antigen receptor (CAR)-engineered NK cells (CAR-NK), and NKG2D CAR-T cells, especially several vaccines targeting MICA/B. This review will inspire the research in NK cell biology in tumor and provide significant hope for improving cancer treatment outcomes by harnessing the potent cytotoxic activity of NK cells.

Related Papers

• → Distinct developmental pathways generate functionally distinct populations of natural killer cells(2024)29 cited
• → Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors(1993)218 cited
• → Measurement of Cytotoxic Activity of NK/LAK Cells(2000)26 cited
• → Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets(1991)6 cited
• → Activation of NK Cells Induces CD4 Expression and Allows HIV−1 Infection.(2006)